Natalia LÓPEZ - Pamplona, Spain
Dr. Natalia López-Andrés has dedicated her scientific career to Biology, graduating from this degree at the University of Navarra. She decided to specialize in cardiovascular sciences doing the doctorate at the Division of Cardiovascular Sciences of the University of Navarra, obtaining the PhD in 2006. She holds a postdoctoral position at the Division of Cardiovascular Sciences in the Centre for Applied Medical Research from 2006 to 2008. During these years she worked with a multidisciplinary research team specialized in the study of heart failure. This expertise enabled Natalia Lopez-Andrés to occupy a postdoctoral position at the INSERM, in the unit U961, from 2008 until January 2013. This unit focuses its research in the mechanisms of action and the diagnostic and therapeutic aspects applied to the field of cardiovascular stiffness-fibrosis and hypercoagulability.
In 2013, she obtained the competitive Miguel Servet contract that allowed her to build a new research group in Navarrabiomed, the Translational cardiovascular research group, in the interface between clinical and basic research. Over the past 7 years her laboratory has investigated the role of Aldosterone/mineralocorticoid receptor and its biotargets in myocardial, vascular and renal fibrosis. Moreover, the program of her group focuses on the study of heart valve diseases. The Program is part of the “Cardiovascular and Renal Diseases Area” of the Health Research Institute of Navarra (IdiSNA). Dr. Natalia Lopez-Andrés is regularly invited as speaker to many international meetings and congresses. She is author or co-author of 70 publications in international journals. As part of her research career, Dr Natalia López-Andrés has effectively developed contacts and collaborations in other countries and universities to enhance her knowledge and capabilities. Dr. López-Andrés participated as a principal investigator in the European FP7 project Fibrotargets, as a work package leader in the COST action ADMIRE and as principal investigator in national (FIS 2015 and FIS 2018) and regional projects (Salud and Industria, Gobierno de Navarra). Moreover, Dr López-Andrés leaded one project supported by G3 Pharmaceuticals (Boston).